Paid Clinical Trials Honolulu

Discover 190 paid clinical trials in Honolulu, Hawaii. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter

Filter results

Results: 190

Chemotherapy with Endocrine TherapyEvaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25

Recruiting

PHASE3

Sponsor:

NRG Oncology

Location:

Honolulu HI, 'Aiea HI, 'Ewa Beach HI, Kailua HIshow 715 more

Code:

NCT05879926

Conditions

Breast Cancer

Eligibility Criteria

Sex: Female

Age: 18 - 60

Healthy Volunteers: Not accepted

Interventions

Ovarian Function Suppression + Aromatase Inhibitor

Adjuvant Chemotherapy + Ovarian Function Suppression

Lenalidomide & DaratumumabS1803, Lenalidomide +/- Daratumumab/rHuPh20 as Post-ASCT Maintenance for MM w/MRD to Direct Therapy Duration

Recruiting

PHASE3

Sponsor:

SWOG Cancer Research Network

Location:

Honolulu HI, 'Aiea HI, Lihue HI, Hilo HIshow 530 more

Code:

NCT04071457

Conditions

Multiple Myeloma

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Lenalidomide

Daratumumab/rHuPH20

Selumetinib vs. Carboplatin/VincristineA Study of the Drugs Selumetinib Versus Carboplatin/Vincristine in Patients With Neurofibromatosis and Low-Grade Glioma

Recruiting

PHASE3

Sponsor:

National Cancer Institute (NCI)

Location:

Honolulu HI, San Francisco CA, Palo Alto CA, Oakland CAshow 104 more

Code:

NCT03871257

Conditions

Low Grade Glioma

Neurofibromatosis Type 1

Visual Pathway Glioma

Eligibility Criteria

Sex: All

Age: 2 - 21

Healthy Volunteers: Not accepted

Interventions

Carboplatin

Magnetic Resonance Imaging

Quality-of-Life Assessment

Questionnaire Administration

Selumetinib Sulfate

ONC201ONC201 in H3 K27M-mutant Diffuse Glioma Following Radiotherapy (the ACTION Study)

Recruiting

PHASE3

Sponsor:

Chimerix

Location:

Honolulu HI, San Francisco CA, Stanford CA, Santa Monica CAshow 53 more

Code:

NCT05580562

Conditions

H3 K27M

Glioma

Eligibility Criteria

Sex: All

Age: 0 - 70+

Healthy Volunteers: Not accepted

Interventions

Dordaviprone (ONC201)

Dordaviprone (ONC201) + Placebo

Placebo

Glofitamab & Polatuzumab VedotinAn Open-Label Study Comparing Glofitamab and Polatuzumab Vedotin + Rituximab, Cyclophosphamide, Doxorubicin, and Prednisone Versus Pola-R-CHP in Previously Untreated Patients With Large B-Cell Lymphoma

Recruiting

PHASE3

Sponsor:

Hoffmann-La Roche

Location:

Honolulu HI, San Francisco CA, Stanford CA, Oakland CAshow 76 more

Code:

NCT06047080

Conditions

Large B-Cell Lymphoma

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Glofitamab

Polatuzumab vedotin

Rituximab

Cyclophosphamide

Doxorubicin

Remibrutinib vs. TeriflunomideEfficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS)

Recruiting

PHASE3

Sponsor:

Novartis Pharmaceuticals

Location:

Honolulu HI, Berkeley CA, Glendale CA, Pasadena CAshow 62 more

Code:

NCT05147220

Conditions

Relapsing Multiple Sclerosis

Eligibility Criteria

Sex: All

Age: 18 - 55

Healthy Volunteers: Not accepted

Interventions

Remibrutinib

Teriflunomide

Mobile InterventionMobile Intervention for Simultaneous Alcohol and Marijuana Use in Young Adults

Recruiting

Sponsor:

Kaiser Permanente

Location:

Honolulu HI

Code:

NCT05991882

Conditions

Alcohol Drinking

Cannabis Use

Eligibility Criteria

Sex: All

Age: 18 - 30

Healthy Volunteers: Not accepted

Interventions

Condition 1: Craving daily+PBS daily

Condition 2: Craving daily+PBS trigger

Condition 3: Craving trigger+PBS daily

Condition 4: Craving trigger+PBS trigger

Condition 5: PBS daily+ PBS trigger

ZiltivekimabA Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Heart Failure and Inflammation

Recruiting

PHASE3

Sponsor:

Novo Nordisk A/S

Location:

Honolulu HI, Palo Alto CA, Stockton CA, Northridge CAshow 160 more

Code:

NCT05636176

Conditions

Heart Failure

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Ziltivekimab

Placebo

Combination ChemotherapyCombination Chemotherapy With or Without Peripheral Stem Cell Transplantation, Radiation Therapy, and/or Surgery in Treating Patients With Ewing's Sarcoma

Recruiting

PHASE3

Sponsor:

University of Leicester

Location:

Honolulu HI, San Francisco CA, Palo Alto CA, Sacramento CAshow 88 more

Code:

NCT00020566

Conditions

Sarcoma

Eligibility Criteria

Sex: All

Age: 0 - 49

Healthy Volunteers: Not accepted

Interventions

dactinomycin

busulfan

doxorubicin hydrochloride

etoposide

ifosfamide

Radiation Therapy with AtezolizumabStudy of Radiation Therapy Followed by Atezolizumab in Stage II or III Non-small Cell Lung Cancer Patients

Recruiting

PHASE2

Sponsor:

National Cancer Institute (NCI)

Location:

Honolulu HI, 'Aiea HI, Lihue HI, Sacramento CAshow 101 more

Code:

NCT04310020

Conditions

Lung Non-Small Cell Carcinoma

Stage II Lung Cancer AJCC v8

Stage III Lung Cancer AJCC v8

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Atezolizumab

Biospecimen Collection

Computed Tomography

Hypofractionated Radiation Therapy

Magnetic Resonance Imaging